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Abstract: Sarcotriol (ST) has been shown to be chemopreventive on 7,12-dimethyl-
benz(a)anthracene (DMBA) initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-
promoted skin tumor development in CD-1 mice in recent studies from our laboratory. The 
objective of this study was to determine the chemopreventive effects of ST on ultraviolet B 
(UVB)-induced skin tumor development in female SKH-1 hairless mice, an experimental 
model relevant to human skin cancer development, and its possible mechanisms of action. 
Female SKH-1 mice were divided into two groups: Control and ST treated. Control was 
topically treated with 100 µL acetone and ST treated group administered with 30 µg ST in 
100 µL acetone one hour before UVB exposure. For UVB-induced tumorigenesis, 
carcinogenesis was initiated and promoted by UVB (180 mJ/cm
2). Group weights and 
tumor counts were taken once every week. After 30 weeks, mice were sacrificed and dorsal 
skin samples were collected. The proteins from the skin sample were further used for SDS-
PAGE and Western blotting using specific antibodies against caspase-3, caspase-8, 
caspase-9 and p53. Tumor multiplicity was found 19.6, 5.2 in the control and ST treated 
groups respectively. Caspase-3, -8, -9 and p53 were significantly (P < 0.05) upregulated in 
ST treated group compared to Control group. Together, this study for the first time 
identifies the chemopreventive effects of ST in UVB-induced carcinogenesis possibly by 
inducing apoptosis and upregulating p53. 
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1. Introduction 
 
Skin cancer is the most common of all cancer types, leading to the diagnosis of more than 1 million 
cases each year in the United States. An estimated 10,850 deaths will occur in 2007 [1], resulting from 
repeated sunlight exposure in which ultraviolet B (UVB) radiation is a major environmental 
carcinogen that induces nonmelanoma skin cancer [2-4].  
Chemical and UVB radiation-induced carcinogenesis in murine and humans is a multistep process 
and has been divided into defined stages of initiation, promotion and progression [5]. UVB acts both as 
an initiator as well as promoter. UVB radiation is absorbed by DNA which causes damage to the DNA, 
primarily at sites of adjacent pyrimidines in the form of dimers [3, 4, 6]. The generation of DNA 
photoproducts has been shown to initiate tumorigenesis. Mechanism(s) of the UVB-induced promotion 
are not been fully understood. Several factors such as generation of reactive oxygen species causing 
oxidative stress and activation of various signaling cascades including the synthesis of prostaglandins 
(PG) play a major role in clonal expansion of UVB-initiated cells into visible skin tumors [7-9].  
Developmrnt of novel strategies to prevent skin cancer represents a desirable goal due to the 
increasing rise in incidence of skin cancer patients throughout the world [10, 11]. Chemoprevention is 
a means of cancer control in which the occurrence of the disease can be entirely prevented, slowed 
down or reversed by the administration of one or more naturally occurring and/or synthetic compounds 
[12, 13]. Nowadays, the supplementation or topical application of synthetic agents viz. retinoids, 
vitamins, inhibitors of ornithine decarboxylase, cyclooxygenase, lipooxygenase and other antioxidant 
compounds including thiols and minerals have gained much attention on one hand, while the use of 
natural agents like polyphenols, monoterpenes, flavonoids, organosulphides, indoles etc have shown 
promise for their development as chemopreventive agents against skin cancer [14, 15]. 
Recent studies have focused on the potential applications of marine organisms, particularly in the 
treatment of human diseases [16]. Several marine natural products are in pre-clinical and clinical 
evaluation, one of which is sarcophytol A [17]. This is a hydroxylated cembranoid isolated from the 
soft coral Sarcophyton glaucum that has shown cancer chemopreventive activity [18]. Another related 
cembranoid is sarcophine, obtained from the Red Sea soft coral Sarcophyton glaucum, which was 
found to possess diverse biological activity [19]. Sarcotriol (ST), a semi-synthetic derivative of 
sarcophine has shown higher activity than the known chemopreventive agent sarcophytol A [18] The 
structures of sarcophine and sarcotriol are shown in Figure 1. Recent studies from our laboratory have 
shown significant chemopreventive effects of ST on 7,12-dimethylbenz(a)anthracene (DMBA)-
initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin tumor development in 
female CD-1 mice by inducing apoptosis and decreasing COX-2 levels [20]. These promising results 
prompted this investigation to study the effects of ST on UVB-induced tumorigenesis in female SKH-1 
hairless mice model. 
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Figure 1. Structures of sarcophine and sarcotriol. 
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The objective of this study was to determine the chemopreventive effects of ST on UVB-induced 
skin tumor development in female SKH-1 hairless mice, an experimental model relevant to human skin 
cancer development. One of the biological responses for tumorigenesis is the loss of apoptotic death. 
Caspase-3, -8 and -9 are proapoptotic proteins which could induce apoptosis, whereas, p53, the tumor 
suppressor gene is involved in many cellular functions including cell cycle inhibition, regulation of 
differentiation, transcription, DNA repair, and apoptosis of cells sustaining DNA damage [3,4]. 
Therefore, the effects of ST on the expressions of caspase-3, -8, -9 and p53 after UVB exposure to 
SKH-1 mice also were determined to elucidate the possible mechanisms of action of ST. 
 
2. Results and Discussion 
 
The effects of ST treatment one hour before the UVB exposure on the tumor incidence and 
multiplicity are shown in Figures 2a and 2b, respectively. 
  
Figure 2a. The effects of ST pretreatment on tumor incidence in UVB-induced 
tumorigenesis in female SKH-1 hairless mice. ST pretreatment delayed the onset of 
tumors from 12
th week till 15
th week when compared to the control group. 
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Figure 2b: The effects of ST pretreatment on tumor multiplicity in the UVB-induced 
tumorigenesis in female SKH-1 hairless mice. ST decreased tumor multiplicity 
throughout the experiment. Each point represents mean number of tumors per mice ± SE 
derived from 27 mice. 
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  The results of the present investigation revealed a delay in the onset of tumorigenesis in the 
animals pretreated with ST. In the Control group, the onset of tumors commenced at 12
th week of 
promotion and reached 100% by the 20
th week, whereas pretreatment with ST one hour before UVB, 
the onset of tumors were delayed until the 15
th week of promotion and, moreover, it was only 75 % 
until the 23
rd week. Tumor incidence was significantly (p < 0.05) lower in ST treated group than 
Control group until 28
th weeks of promotion. By the end of the experiment, tumor incidence was found 
to be 100 and 92 % in the Control and ST treated group respectively. As shown in Figure 2b, ST 
treatment resulted in a significant (P < 0.05) reduction in the number of tumors per mouse compared to 
the Control group throughout the duration of experiment. The mean number of tumors at the end of 
experiment in Control and ST treated group was found to be 19.6 and 5.2 respectively. These results 
indicated that ST inhibited skin tumor development in both tumor incidence, to a lesser extent, and 
tumor multiplicity in the ST treated groups (Figure 3). There was no significant difference in the 
average mouse weight between the Control and ST treated group throughout the experiment (data not 
shown). Moreover, the skin of mice that were treated with ST appeared to be healthy and no toxic 
symptoms were observed.  
One biological event responsible for tumorigenesis is the loss of apoptotic death of transformed 
cells [21]. In most cancers, the apoptotic pathway of tumor cells is compromised with a survival 
advantage over the normal cells [22]. Induction of apoptosis is a key event, which controls the 
outcome of chemopreventive efficacy of an agent under investigation [22, 23]. A fundamental 
biochemical event that starts apoptosis is the activation of caspases [24]. Apoptosis occurs through two 
pathways; extrinsic and intrinsic [25]. The extrinsic pathway is activated by the ligation of death 
receptors, which ultimately leads to the activation of caspase-8 [25]. In the intrinsic pathway of Mar. Drugs 2007, 5        201 
 
 
apoptosis, mitochondrial dysfunction takes place causing the release of cytochrome c into the cytosol, 
which finally leads to the activation of caspase-9 [26]. Finally the upstream caspases-9 and -8 
converge to caspase-3 leading to apoptosis [25]. 
 
Figure 3: The skin cancer protective effect of sarcotriol: skin tumor incidence and 
multiplicity were significantly reduced in mice pretreated with sarcotriol (bottom) 
compared to the untreated control (top). 
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Based on the hypothesis that ST induces apoptosis by upregulating the caspase levels as its 
possible mechanism of chemoprevention against skin tumor development in CD-1 mice [16], the 
effects of ST on caspase-3 were analyzed. As shown in Figure 4, ST significantly (P < 0.05) 
upregulated the levels of caspase-3. We observed that the value of caspase-3 as compared in ST treated 
group was found to be 4.9 fold higher than Control group. In order to assess the mechanism of 
caspase-3 activation, a further study was carried out to find out whether caspase-9 and
 -8 are activated 
as upstream effectors leading to caspase-3
 activation. We observed a significant (P < 0.05) increase in 
caspase-9 and -8 activities as shown in Figure 5. The levels of caspase-8 in ST treated group were 
found to be 5.7 fold higher than Control. Whereas the values of caspase-9 in ST treated group were 3.9 
fold higher than Control. These results suggest that ST induced apoptotic cell death might be mediated 
by both extrinsic and intrinsic pathways of apoptosis in tumor cells in UVB-induced carcinogenesis. 
 
Figure 4. The effects of ST pretreatment on proapoptotic proteins, caspase-3, 8 and 9, on 
UVB-irradiated skin tumors of SKH-1 hairless mice. Values represent mean ± SE derived 
from at least three mice. Values of ST are percentages of control values quantitated by 
densitometry. 
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The gene p53 is one of the most frequently mutated in UVB-induced carcinogenesis [27]. It plays 
an important role in the induction of apoptosis through caspase dependent as well as caspase 
independent pathways [3].  The p53 tumor suppressor gene is essential in maintaining the genomic 
integrity of cells through its role in allowing repair of DNA damage or apoptosis [22]. A relationship 
between exogenous tumor induction and p53 expression has been reported in UVB-induced skin 
papillomas and carcinomas of the skin [28, 29]. The p53 tumor suppressor gene induces apoptosis in 
response to cellular stresses such as DNA damage, hypoxia, and oncogene activation [30]. In order to 
unravel the mechanism behind the induction of apoptosis by ST treatment we further assessed the 
levels of p53 in UVB-induced carcinogenesis. As expected there was a significant (P < 0.05) 
upregulation of p53 levels in ST treated group compared to Control. The value of p53 was found to be 
1.9 fold higher in ST treated group when compared to the Control; data are shown in Figure 5.  Mar. Drugs 2007, 5        203 
 
 
Figure 5. The effects of ST pretreatment on p53 on UVB-irradiated skin tumors of SKH-
1 hairless mice. Values represent mean ± SE derived from at least three mice. Values of 
ST are percentages of control values quantitated by densitometry. 
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3. Conclusions 
 
Taken together from the above results, the effectiveness of ST as chemopreventive agent appears to 
be very promising in UVB-induced skin cancer control. The mechanism behind its chemoprevention 
might be possibly by inducing apoptosis, upregulating p53, contributing to its overall cancer 
chemopreventive effects in the UVB-induced mouse skin cancer model. 
  
4. Experimental 
 
4.1. General 
 
Sarcophine was isolated from the soft coral Sarcophyton glaucum collected from several locations 
of the Red Sea in Egypt. Phenylmethylsulfonylfluoride (PMSF), Tween 20, sodium chloride, 
ammonium persulphate, sodium lauryl sulphate, acetic acid, leupeptin and pepstatin were obtained 
from Sigma Chemical Company (St. Louis, MO). Acrylamide was purchased from Bio Rad 
Laboratories, (Hercules, CA), glycine, sodium dodecyl sulphate (SDS) and Tris from USB Corporation 
(Cleveland, OH), and nitrocellulose membrane from Bioexpress (Kaysville, UT).  Primary antibodies 
against caspase-3 were purchased from Cayman Chemical Company (Ann Arbor, MI), primary 
antibody against caspase-8, -9, and horseradish peroxidase conjugated goat anti-rabbit secondary 
antibodies were purchased from BD Biosciences (Rockville, MD) and p53 from Abcam Inc. 
(Cambridge, USA). ECL Kit was bought from Amersham Biosciences (Piscataway, NJ). Other 
reagents were obtained in their highest purity grade available commercially. 
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4.2. Materials 
 
Sarcophine was isolated from the soft coral Sarcophyton glaucum by multiple extraction with 
petroleum ether at room temperature following the reported procedure [19] at the laboratories of the 
Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt. The 
dried extract was evaporated under reduced pressure and chromatographed on silica gel column using 
hexane: ethyl acetate (1:2) as eluent. Pure sarcophine was obtained by crystallization from ethanol. ST 
was synthesized according to the folowing procedure: Sarcophine was reduced to its lactone ring-
opened analogue (50 mg, 0.16 mmol) to which selenium dioxide (35.5 mg, 0.32 mmol) in dry 1,4-
dioxane (15 mL) was added and the reaction mixture was stirred at room temperature for 4 h. Water 
was then added, and the product was extracted with CH2Cl2. Saturated NaHCO3 solution was used to 
wash the CH2Cl2 layer which was dried over anhydrous Na2SO4. The solvent was evaporated and the 
residue was chromatographed on silica gel using hexane - acetone (1:1) as an eluent to obtain ST (12 
mg, 23%) [18]. 
 
4.3. UVB-induced Tumorigenesis Protocol:   
 
4.3.1. UVB Source:  
  
The UVB irradiation unit, manufactured by Daavlin Corporation (Ohio, USA) consists of four 
UVB lamps. The exposure dose can be controlled by using two Daavlin flex control integrating 
dosimeters. The dose of UVB exposure is expressed in millijoules/cm
2. 
 
4.3.2. Animals: 
 
Female SKH-1 mice (5 weeks old) were purchased from Charles River Laboratories (Wilmington, 
MA). The animals were housed ten per cage at 22 ± 1
0C and 50 ± 10% relative humidity and subjected 
to a 12h light/ 12h dark cycle in the College of Pharmacy animal facility. They were acclimatized for 1 
week before use and provided food and water ad libitum. 
 
4.3.3. Experiment: 
 
The tumorigenesis protocol as described by Dwivedi et al. [31] was used. Female SKH-1 mice 
randomly divided into two groups, Control and ST treated. Both initiation as well as promotion was 
induced by UVB radiation (180mJ/cm
2). During the initiation phase, Control was treated with acetone 
(100 µL) and ST treated with ST (100 μL, 30 µg/100 µL of acetone) one hour prior to UVB treatment. 
This was done every day and was continued until 14 days. Ten days after the initiation phase, 
promotion phase was started. During the promotion phase, both Control and ST treated groups were 
treated in the same way as they were treated during the initiation phase. But during the promotion 
phase, the treatment was done only twice a week (Tuesday and Friday) and was continued until the 
next 30 weeks. Tumor counts and group weights were taken once every week. 
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4.4 Lysate Preparation 
 
Mice from UVB-induced tumorigenesis protocol were sacrificed after 30 weeks by cervical 
dislocation and epidermis was collected from mice of Control and ST Treated groups respectively. The 
fat and tumors in the skin of these three groups were scraped by scalpel, and then epidermis was 
homogenized by an OMNI GLH-115 homogenizer in 0.1 mM Tris-HCl (pH 7.4) containing 0.15 M 
sodium chloride. The epidermal homogenate was filtered by cheesecloth and then filtrate was 
centrifuged at 10,000 g for 20 min in the Beckman J2-21 Centrifuge. This pellet combined with 5% 
SDS containing 1% 100 mM PMSF, 0.5% leupepth and 0.5% pepstatin was allowed to pass through 
25G needle and centrifuged at 13,000 g for 20 min. The supernatant was collected, allowed to pass 
through 25G needle again and heated in heating block (100 
○C) for 5 min. and epidermis was collected 
from mice of Control and ST treated groups respectively. The cell pellet of mice obtained as a result of 
ultracentrifugation is taken in an Eppendorf tube and lysed in 5% SDS containing protease inhibitors 
leupeptin, pepstatin and phenyl methyl suphonyl floride (PMSF) as described by Kundoor et al. [16] 
and Zhang et al. [32]. 
 
4.5. Western Blot Analysis of Caspase -3, -8, -9 and p53 
 
Protein concentration was measured in each cell lysate by the protein assay (Pierce, Illinois) with 
albumin as a standard. Equal amounts of protein lysates (60 μg) were resolved on 12.5% SDS-poly-
acrylamide gels and transferred to nitrocellulose membrane. Membranes were blocked for 1 h in 5% 
skim milk in TBS (10 mM Tris, 100 mM NaCl), and then probed with primary antibodies against 
caspase-3, -8, -9 and p53. The secondary antibodies conjugated to horseradish peroxidase were used 
for development with the enhanced chemiluminescence detection (ECL) kit. The Western blots were 
quantified using a UVP Biochem Gel Documentation system (UVP, Inc., Upland, California). Caspase 
-3, 8- ,-9 and p53 data were normalized using beta-actin as the housekeeping protein used routinely in 
our laboratories. 
 
4.6. Statistical Analysis 
 
The INSTAT software package (Graph Pad, San Diego, CA) was used to analyze the data. Chi Square 
was used for analyzing the data on tumor incidence. Student’s t test was used to compare the tumor 
multiplicity, weight gain, caspase-3, -8, -9 and p53 levels in UVB-induced carcinogenesis. Significance in 
all the cases was considered at P < 0.05. 
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